On Jan. 7, 2025, the FDA issued its draft guidance, “Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations.” In its latest draft guidance on medical devices, the FDA provides recommendations on the documentation and information that should be included in marketing submissions for devices that include AI-enabled device software functions.
FDA Releases Draft Guidance on AI-Enabled Medical Devices
